135 related articles for article (PubMed ID: 34108312)
21. Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon-alpha combined with hydroxyurea.
Jehn U; Heinemann V
Cancer Detect Prev; 1998; 22(3):258-64. PubMed ID: 9618049
[TBL] [Abstract][Full Text] [Related]
22. Progression of chronic myeloid leukemia to blast crisis during treatment with imatinib mesylate.
Xu Y; Wahner AE; Nguyen PL
Arch Pathol Lab Med; 2004 Sep; 128(9):980-5. PubMed ID: 15338554
[TBL] [Abstract][Full Text] [Related]
23. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
[TBL] [Abstract][Full Text] [Related]
24. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
[TBL] [Abstract][Full Text] [Related]
25. [Nonoliguric acute renal failure complicated with tumor lysis syndrome in chronic myelocytic leukemia in lymphoid crisis].
Kobayashi R; Naito H; Shikano T; Ishikawa Y; Matsumoto T; Tonooka T
Rinsho Ketsueki; 1991 Jan; 32(1):43-6. PubMed ID: 2020116
[TBL] [Abstract][Full Text] [Related]
26. [Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia].
Watanabe N; Tani M; Tanaka Y; Kurata M; Matsushita A; Maeda A; Nagai K; Takahashi T
Rinsho Ketsueki; 2004 Mar; 45(3):243-6. PubMed ID: 15103940
[TBL] [Abstract][Full Text] [Related]
27. Bilineal Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review.
Gao X; Li J; Wang L; Lin J; Jin H; Xu Y; Wang N; Zhao Y; Liu D; Yu L; Wang Q
Am J Case Rep; 2016 Oct; 17():793-798. PubMed ID: 27784881
[TBL] [Abstract][Full Text] [Related]
28. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
Kuyama J; Take H
Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
[TBL] [Abstract][Full Text] [Related]
29. [Myeloid crisis of chronic myelogenous leukemia showing dramatic response to mithramycin and hydroxyurea combination].
Ueki K; Tsuchida A; Murakami H; Karasawa M; Kobayashi N; Omine M; Naruse T
Rinsho Ketsueki; 1989 Oct; 30(10):1840-2. PubMed ID: 2531808
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous reversion from blast to chronic phase after withdrawal of imatinib mesylate in a patient with chronic myelogenous leukemia.
Liu NS; O'Brien S
Leuk Lymphoma; 2002 Dec; 43(12):2413-5. PubMed ID: 12613534
[TBL] [Abstract][Full Text] [Related]
32. Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case Report.
Waseem Hajjar AH; Abbarh S; Al-Mashdali A; Alshurafa A; Abu-Tineh M; Qasim H; Ahmed K; Yassin MA
Cureus; 2022 Apr; 14(4):e24386. PubMed ID: 35619871
[TBL] [Abstract][Full Text] [Related]
33. Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis.
Bin Salman AA; Zaidi ARZ; Altaf SY; AlShehry NF; Tailor IK; Motabi IH; Zaidi SZA
Am J Case Rep; 2020 Sep; 21():e922971. PubMed ID: 32920590
[TBL] [Abstract][Full Text] [Related]
34. [Isolated cerebellar tumor formation in a patient with blastic crisis of chronic myelogenous leukemia].
Takahashi N; Chubachi A; Watanabe S; Nishinari T; Nimura T; Imai H; Fukushima Y; Miura AB
Rinsho Ketsueki; 1992 Sep; 33(9):1257-62. PubMed ID: 1433948
[TBL] [Abstract][Full Text] [Related]
35. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
Goto H; Tsurumi H; Hara T; Moriwaki H
Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
[TBL] [Abstract][Full Text] [Related]
36. [Development of Ph negative acute myeloid leukemia in a patient with minor-BCR/ABL positive chronic myeloid leukemia achieving a partial cytogenetic response during tyrosine kinase inhibitor treatment].
Fujii S; Miura I; Tanaka H
Rinsho Ketsueki; 2015 Jun; 56(6):681-6. PubMed ID: 26256879
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
Wang DP; Liang MY; Zhang XH; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
[TBL] [Abstract][Full Text] [Related]
39. [Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients].
Creutzig U; Ritter J; Zimmermann M; Klingebiel T
Klin Padiatr; 1996; 208(4):236-41. PubMed ID: 8926689
[TBL] [Abstract][Full Text] [Related]
40. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
